These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17650054)

  • 1. Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes.
    Lambert TJ
    J Clin Psychiatry; 2007; 68 Suppl 6():10-3. PubMed ID: 17650054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
    Buckley PF
    J Clin Psychiatry; 2007; 68 Suppl 6():5-9. PubMed ID: 17650053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
    Weiden PJ; Buckley PF
    J Clin Psychiatry; 2007; 68 Suppl 6():14-23. PubMed ID: 17650055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J
    Med Hypotheses; 2006; 67(3):517-23. PubMed ID: 16632226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical stakes when switching from one antipsychotic to another].
    Constant É
    Encephale; 2013 Dec; 39(6):439-44. PubMed ID: 24238644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticholinergics during neuroleptic treatment. Value and withdrawal].
    Betermiez P; Delahousse J; Pedinielli JL
    Encephale; 1986; 12(4):169-74. PubMed ID: 2878801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
    Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.
    Cerovecki A; Musil R; Klimke A; Seemüller F; Haen E; Schennach R; Kühn KU; Volz HP; Riedel M
    CNS Drugs; 2013 Jul; 27(7):545-72. PubMed ID: 23821039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
    Schneider AL; Mosier KE; Tempier RP
    J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming hurdles to achieving good physical health in patients treated with atypical antipsychotics.
    Fagiolini A
    Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S102-7. PubMed ID: 18346597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 18. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics.
    Correll CU
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S12-21. PubMed ID: 20620881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repercussions of the withdrawal of thioridazine].
    Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
    Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.